WATCHMAN Implanted

First to Implant New Watchman FLXTM Device

(CAMDEN, NJ) — Cooper is one of approximately 40 sites in the United States and the only hospital in the Philadelphia region participating in a clinical trial for Boston Scientific’s Watchman FLXTM device. The Watchman FLX is the next generation of a potentially life-changing catheter-based (or non-surgically delivered) device designed to close the left atrial appendage in order to reduce the risk of stroke in certain patients with atrial fibrillation (AFib). The Cooper…

Read More
Cooper Hospital

Top Hospital For Congestive Heart Failure

(Camden, NJ) – Cooper University Health Care was recognized as a top performing hospital for treating congestive heart failure in U.S. News & World Report’s…

Read More
Dr. Fredric Ginsberg

Frederic Ginsberg Medical Dir. of Cardiac Services

(Camden, NJ) – Fredric L. Ginsberg, M.D., FACC, FACCP, a clinical cardiologist and co-medical director of the Cooper Heart Institute, has been named medical director…

Read More
Cooper and Inspira Join Forces

Largest Cardiac Program in S. Jersey

(Camden and Mullica Hill, NJ) – Cooper University Health Care and Inspira Health Network today announced that they have formed a joint venture to completely…

Read More
Scroll to Top